Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 7/2018

Content (9 Articles)

The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus

  • Leading Article

Hadi Fattah, Volker Vallon

The Expanding Role of Ketamine in the Emergency Department

  • Review Article

Sophia Sheikh, Phyllis Hendry

Chemotherapy-Induced Neutropenia as a Prognostic and Predictive Marker of Outcomes in Solid-Tumor Patients

  • Review Article

Pashtoon Murtaza Kasi, Axel Grothey

Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers

  • Adis Drug Evaluation

Lesley J. Scott

Correction to: Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers

  • Correction

Lesley J. Scott

Baricitinib: A Review in Rheumatoid Arthritis

  • Adis Drug Evaluation

Zaina T. Al-Salama, Lesley J. Scott

Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension

  • Open Access
  • Adis Drug Evaluation

Sheridan M. Hoy

Ibalizumab: First Global Approval

  • Open Access
  • AdisInsight Report

Anthony Markham

Correction to: Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations

  • Correction

George G. Zhanel, Courtney K. Lawrence, Heather Adam, Frank Schweizer, Sheryl Zelenitsky, Michael Zhanel, Philippe R. S. Lagacé-Wiens, Andrew Walkty, Andrew Denisuik, Alyssa Golden, Alfred S. Gin, Daryl J. Hoban, Joseph P. Lynch III, James A. Karlowsky

Apr 18
Issue: 6/2018
Jun 18
Issue: 9/2018

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images